Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study AstraZeneca Vaccine also appears effective against Brazil COVID-19 variant

[Treyfish]

MARCH 8, 20215:07 PM
UPDATED 31 MINUTES AGO
Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study

By Michael Erman

NEW YORK (Reuters) - The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.

Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found...:tiphat:https://www.reuters.com/article/us-h...source=twitter

 

[kiwibird]

https://www.reuters.com/article/hea...against-brazil-covid-19-variant-idUSS0N2KF035

RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil?s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.

...snip